HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

mofarotene

structure given in first source
Also Known As:
4-((2-(p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)propenyl)phenoxy)ethyl))morpholine; Ro 40-8757; Ro-40-8757; arotinoid Ro 40-8757
Networked: 15 relevant articles (1 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Fink-Puches, Regina: 1 article (12/2004)
2. Helige, Christine: 1 article (12/2004)
3. Hofmann-Wellenhof, Rainer: 1 article (12/2004)
4. Smolle, Josef: 1 article (12/2004)
5. Boiocchi, Mauro: 1 article (02/2003)
6. Cariati, Roberta: 1 article (02/2003)
7. De Rossi, Anita: 1 article (02/2003)
8. Dolcetti, Riccardo: 1 article (02/2003)
9. Righetti, Elisabetta: 1 article (02/2003)
10. Rizzo, Silvana: 1 article (02/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Melanoma (Melanoma, Malignant)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Breast Neoplasms (Breast Cancer)
5. Pancreatic Neoplasms (Pancreatic Cancer)

Related Drugs and Biologics

1. Retinoids
2. Fluorouracil (Carac)
3. Cell Cycle Proteins
4. Vinculin
5. Etoposide (VP 16)
6. Cisplatin (Platino)
7. Tretinoin (Retinoic Acid)
8. mofarotene
9. morpholine
10. Therapeutic Uses

Related Therapies and Procedures

1. Therapeutics
2. Chemoprevention